8-K: FOXO Technologies Settles Debt and Plans Reverse Split
Current Report (8-K)
FOXO Technologies has reached a settlement with J.H. Darbie & Co. and received majority shareholder approval for a massive reverse stock split.
Summary
- Entered into a settlement agreement with J.H. Darbie & Co. to resolve outstanding obligations under previous advisory and placement agreements.
- Settlement terms include the issuance of 400 shares of Series D Preferred Stock and a $175,000 cash payment plan.
- Cash payments are structured as seven equal monthly installments of $25,000, ending December 31, 2026.
- Majority shareholder (Rennova Health, Inc.) approved a reverse stock split at a ratio between 1:1,000 and 1:1,0000.
- The previously approved 2025 reverse stock split plan has been formally abandoned.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as highly negative due to the extreme nature of the proposed reverse stock split and the company's ongoing need to settle debts with equity.
Positives
- Resolution of outstanding legal and financial obligations with J.H. Darbie & Co. removes a source of potential litigation.
- The settlement provides a structured, manageable cash payment schedule through the end of 2026.
Negatives
- The proposed reverse stock split ratio (up to 1:10,000) indicates extreme share dilution or significant historical price erosion.
- The company remains in a precarious financial position, necessitating the issuance of preferred stock to settle debts.
- Default on the settlement agreement triggers conversion rights for J.H. Darbie, potentially increasing dilution.
Risks
- Extreme dilution risk for existing common shareholders due to the high reverse split ratio.
- Potential for further equity dilution if the company defaults on the $175,000 settlement payment.
- Dependence on majority shareholder approval for all major corporate actions.
- Regulatory risk regarding FINRA approval for the proposed reverse stock split.
Future Outlook
The company intends to execute a reverse stock split between 1:1,000 and 1:10,000 by November 30, 2026, subject to FINRA approval, to address its capital structure.
Management Comments
- The Board of Directors has been granted sole discretion to determine the final reverse split ratio within the approved range.
Industry Context
StockSavvy.ai notes that FOXO Technologies is utilizing extreme reverse stock splits, a common but often desperate tactic among micro-cap companies attempting to maintain exchange listing compliance or clean up capital structures after significant value destruction.
Comparison to Industry Standards
- The 1:1,000 to 1:10,000 reverse split ratio is significantly more aggressive than standard market practice, which typically ranges from 1:5 to 1:50.
- The reliance on majority shareholder written consent is common for controlled companies but highlights a lack of minority shareholder influence.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reverse Stock Split Authorization | Majority shareholder approved a reverse split ratio of 1:1,000 to 1:10,000. | 2026-05-18 | Significant reduction in outstanding share count and potential for extreme dilution or consolidation of value. |
Legal Proceedings
- Settlement Agreement and Release with J.H. Darbie & Co. resolves all claims related to previous Finders Fee, Advisory, and Private Placement agreements.
Related Party Transactions
- Rennova Health, Inc., controlled by the Company's CEO, acted as the Majority Stockholder in approving the reverse stock split.
Stakeholder Impact
- Existing shareholders face extreme dilution or consolidation of their holdings due to the massive reverse split ratio.
- Creditors (J.H. Darbie) have secured a settlement involving both cash and equity.
Next Steps
- Mail definitive Information Statement to stockholders.
- Obtain FINRA approval for the reverse stock split.
- Execute reverse stock split before November 30, 2026.
- Commence monthly cash payments to J.H. Darbie starting May 31, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-05-15 | Date of Settlement Agreement with J.H. Darbie & Co. |
| 2026-05-18 | Record date for majority shareholder written consent. |
| 2026-05-20 | Filing of preliminary Information Statement (PRE 14C). |
| 2026-05-31 | Commencement of cash payments to J.H. Darbie. |
| 2026-11-30 | Deadline for executing the reverse stock split. |
| 2026-12-31 | Final cash payment due to J.H. Darbie. |
Recommendation
sellThe combination of a 1:10,000 reverse split and the need to settle basic advisory debts with preferred stock indicates severe financial distress and a lack of long-term value for common equity holders.
Keywords
FOXO Technologies, Reverse Stock Split, Debt Settlement, Series D Preferred Stock, Shareholder Dilution, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.